Our team recently had the pleasure of attending BIO KOREA 2015, a convention created to share the latest information and technology in the health industry and to establish corporate partnerships among global experts.
As the largest health industry convention in Asia, BIO KOREA hosts about 20,000 participants and 470 companies from 40 nations around the world, providing a networking venue for experts and researchers of the world’s health industry.
Growth for Asia’s pharmaceutical and clinical trials markets is continuing at double-digit rates, with particularly strong growth predicted for China, South Korea, Taiwan, and Singapore through 2017. Clinipace has long understood the importance of this region, and in anticipation of the high demand by clients for localized operations, the company expanded its Asian presence with the acquisition of Choice Pharma. The merger extended Clinipace’s global footprint to include 20 operational offices in 15 countries, including new offices in Taiwan, China, Hong Kong, South Korea, Vietnam, Singapore, and Malaysia.